首页|慢性乙肝患者血清甲状腺激素对病情、预后的评估价值

慢性乙肝患者血清甲状腺激素对病情、预后的评估价值

扫码查看
目的:研究血清甲状腺激素水平检测对慢性乙肝患者病情及预后评估的意义.方法:回顾性分析 2021 年 4 月—2023 年 5 月于九江市第三人民医院接受治疗的 80 例慢性乙肝患者作为研究组,同期在本院接受体检的 30 名健康志愿者为对照组,研究组接受 3 个月的常规抗病毒治疗.比较研究组治疗前和对照组患者血清甲状腺激素水平.比较不同病情严重程度的慢性乙肝患者治疗前血清甲状腺激素水平差异.Spearman相关性分析慢性乙肝患者血清甲状腺激素水平与病情的相关性.记录慢性乙肝患者抗病毒治疗预后,比较不同预后的慢性乙肝患者血清甲状腺激素水平.应用受试者操作特征(ROC)曲线分析慢性乙肝患者血清甲状腺激素水平对预后的预测价值.结果:研究组与对照组游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)水平比较,差异均无统计学意义(P>0.05);研究组促甲状腺激素(TSH)低于对照组(P<0.05).不同病情严重程度的慢性乙肝患者FT3、FT4 比较,差异均无统计学意义(P>0.05);血清TSH比较,差异有统计学意义(P<0.05);重型组TSH水平低于中型组、轻型组,中型组TSH水平低于轻型组(P<0.05).Spearman相关性分析显示TSH与慢性乙肝患者病情呈显著负相关(rs=-0.654,P<0.01).治疗后,11 例乙肝表面抗原(HBsAg)转阴被纳入HBsAg转阴组,其余 69 例纳入HBsAg未转阴组.HBsAg转阴组患者TSH显著高于HBsAg未转阴组(P<0.05).不同预后的慢性乙肝患者血清FT3、FT4 比较,差异均无统计学意义(P>0.05).ROC曲线结果显示,TSH水平预测慢性乙肝患者预后的AUC为 0.629(P=0.114).结论:通过检测血清甲状腺激素TSH水平,可作为慢性乙肝患者病情分型的重要参考依据,但其与慢性乙肝患者抗病毒治疗预后的关系仍有待探究.
Evaluation Value of Serum Thyroid Hormones in Condition and Prognosis of Patients with Chronic Hepatitis B
Objective:To study the significance of serum thyroid hormones detection in condition and prognosis evaluation of patients with chronic hepatitis B.Method:A retrospective analysis of 80 patients with chronic hepatitis B who were treated in Jiujiang Third People's Hospital from April 2021 to May 2023 were selected as the study group,and 30 healthy volunteers who received physical examination in the our hospital during the same period were selected as the control group,the study group received 3 months of conventional antiviral treatment.Serum thyroid hormone levels in the study group before treatment were compared with those in the control group.Serum thyroid hormone levels in patients with different severity of chronic hepatitis B before treatment were compared.Spearman correlation analysis was conducted to discuss the correlation between serum thyroid hormone levels and the severity of chronic hepatitis B.Serum thyroid hormone levels in patients with different prognoses were recorded,and the serum thyroid hormone levels of chronic hepatitis B patients with different prognosis were compared.The prognostic value of serum thyroid hormone levels in patients with chronic hepatitis B was analyzed by receiver operating characteristic(ROC)curve.Result:There were no statistically significant differences in the levels of free triiodothyronine(FT3)and free thyroxine(FT4)between the study group and the control group(P>0.05);the level of thyroid stimulating hormone(TSH)in the study group was lower than that in the control group(P<0.05).There were no statistically significant differences in FT3 or FT4 among patients with different severity of chronic hepatitis B(P>0.05);there was statistically significant difference in serum TSH(P<0.05);TSH level in severe group was lower than that in moderate group and mild group,and the level of TSH in moderate group was lower than that in mild group(P<0.05).Spearman correlation analysis found that TSH was negatively correlated with the condition of patients with chronic hepatitis B(rs=-0.654,P<0.01).After treatment,hepatitis B surface antigen(HBsAg)in 11 cases turned negative were included in the HBsAg clearance group,and the other 69 cases were included in the non-HBsAg clearance group.TSH in HBsAg clearance group was significantly higher than that in the non-HBsAg clearance group(P<0.05).There were no statistically significant differences in serum FT3 or FT4 between patients with different prognoses(P>0.05).ROC curve indicated that the AUC of TSH level to predict the prognosis of chronic hepatitis B was 0.629(P=0.114).Conclusion:Detecting serum thyroid hormone TSH levels in patients with chronic hepatitis B can be used as important reference for condition evaluation.However,the relationship with the prognosis of antiviral treatment in patients with chronic hepatitis B needs further study.

Thyroid hormoneHepatitis BHepatitis B surface antigenPrognosis

苏润林、王林燕、时丽

展开 >

九江市第三人民医院检验科 江西 九江 332000

九江市中医医院检验科 江西 九江 332000

甲状腺激素 乙型肝炎 乙肝表面抗原 预后

2024

中国医学创新
中国保健协会

中国医学创新

影响因子:1.706
ISSN:1674-4985
年,卷(期):2024.21(15)
  • 16